Concepedia

Jaclyn P. Lyman

JP

Statistics

Publications

8

Citations

1K

H-Index

8

Active since

2014

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

The University of Texas MD Anderson Cancer Center

University of California, San Francisco

Bristol-Myers Squibb (United States)

Jaclyn P. Lyman is an author at Memorial Sloan Kettering Cancer Center specializing in cancer therapeutics, oncology, and radiation oncology.

Top concepts

Publications per year

2014–2022

8

Publications

8

Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Lacey Padrón, Deena M. Maurer, Mark H. O’Hara et al. · Nature Medicine · 2022 · 316 citations · Full text

, , +13

CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study

Mark H. O’Hara, Eileen M. O’Reilly, Gauri R. Varadhachary et al. · The Lancet Oncology · 2020 · 286 citations

, , +7

Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast Cancer

Mary Jo Fackler, Zoila A. Lopez‐Bujanda, Christopher B. Umbricht et al. · Cancer Research · 2014 · 158 citations · Full text

Prognostic Impact of 21-Gene Recurrence Score in Patients With Stage IV Breast Cancer: TBCRC 013

Tari A. King, Jaclyn P. Lyman, Mithat Gönen et al. · Journal of Clinical Oncology · 2016 · 82 citations

A prospective analysis of surgery and survival in stage IV breast cancer (TBCRC 013).

Tari A. King, Jaclyn P. Lyman, Mithat Gönen et al. · Journal of Clinical Oncology · 2016 · 65 citations

, , +16

Rows per page

1–5 of 8